PARP inhibitor improves progression-free survival in patients with advanced breast cancers
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP […]
» Read moreHome »
nohealthproblemsnews.com
Home »
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP […]
PARP inhibitor improves progression-free survival in patients with advanced breast cancers